Panbela Therapeutics, Inc. (PBLA)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 11, 2026, 4:00 PM EST
Panbela Therapeutics Market Cap
Panbela Therapeutics has a market cap or net worth of $485 as of August 12, 2026. Its market cap has decreased by -99.94% in one year.
Market Cap
485.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since October 19, 2015, Panbela Therapeutics's market cap has decreased from 89.28M to 485.00, a decrease of -100.00%. That is a compound annual growth rate of -67.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 485.00 | -50.05% |
| Dec 31, 2025 | 971.00 | -99.95% |
| Dec 31, 2024 | 1.84M | -70.55% |
| Dec 29, 2023 | 6.27M | 109.12% |
| Dec 30, 2022 | 3.00M | -87.09% |
| Dec 31, 2021 | 23.21M | -32.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pathfinder Cell Therapy | 667.00 |
| Proteonomix | 633.00 |
| Amarantus BioScience Holdings | 630.00 |
| Alzex Neuropharma | 602.00 |
| Adynxx | 581.00 |
| GlobeImmune | 575.00 |
| Mera Pharmaceuticals | 537.00 |
| Iterum Therapeutics | 528.00 |